跳至: [中文]   [數字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 請輸入前幾個字:

顯示項目9026-9050 / 12927. (共518頁) << < 357 358 359 360 361 362 363 364 365 366 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2008-11	Pharmacokinetics, micro-SPECT/CT imaging and therapeutic efficacy of 188Re-DXR-liposome in C26 colon carcinoma ascites mice model	Nuclear Medicine and Biology. 2008 Nov;35(8):883-893.
2013-08-01	Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression	Cell. 2013 Aug 1;154(3):556-568.
2015-07	Pharmacological induction of human fetal globin gene in hydroxyurea-resistant primary adult erythroid cells	Molecular and Cellular Biology. 2015 Jul;35(14):2541-2553.
2020-06	Pharmacological inhibition of cathepsin S suppresses abdominal aortic aneurysm in mice	European Journal of Vascular and Endovascular Surgery. 2020 Jun;59(6):990-999.
2013-10-11	Pharmacological profiles of oligomerized mu-opioid receptors	Cells. 2013 Oct 11;2(4):689-714.
2020-04	Pharmacological studies of morphine in a novel humanized mu opioid receptor mouse model	FASEB Journal. 2020 Apr;34(S1):Abstract number 02835.
2022-11-17	Pharmacometabolomic study of drug response to antihypertensive medications for hypertension marker identification in Han Chinese individuals in Taiwan	Computational and Structural Biotechnology Journal. 2022 Nov 17;20:6458-6466.
2017-12-28	Pharmacophore anchor models of flaviviral NS3 proteases lead to drug repurposing for DENV infection	BMC Bioinformatics. 2017 Dec 28;18(Suppl. 16):Article number 548.
2023-06	Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors	Journal of Clinical Oncology. 2023 Jun;41(16, Suppl.):Meeting Abstract 3148.
2022-02	Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors	Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660.
2021-06-12	Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers	Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253.
2021-05	A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy	Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025.
2022-02-01	A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1	Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):378.
2017-09	A Phase 3 Study of nivolumab (Nivo) in previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Updated results and subset analysis by PD-L1 expression (ATTRACTION-02)	Annals of Oncology. 2017 Sep;28(Suppl. 5):Meeting Abstract 617O.
2002	Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma	International Journal of Cancer. 2002;Suppl. 13:336-337.
2006-11	Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma	Cancer Chemotherapy and Pharmacology. 2006 Nov;58(5):654-664.
2021-03-01	Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors	Scientific Reports. 2021 Mar 1;11:Article number 4834.
2021-04	Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors	Oncologist. 2021 Apr;26(4):e567-e579.
2016-02	Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 745.
1997-07	A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions	Anti-Cancer Drugs. 1997 Jul;8(6):565-573.
2013-12	Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma	Journal of Hepatology. 2013 Dec;59(6):1271-1277.
2021-05	Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia	Cancer Medicine. 2021 May;10(9):2946-2955.
2020-05	Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1, in patients with pretreated biliary tract cancer	Journal for ImmunoTherapy of Cancer. 2020 May;8(1):Article number e00056.
2021-07	A phase I study of biweekly abraxane in combination with oxaliplatin and oral S-1/leucovorin as first line treatment for advanced gastric, pancreatic and biliary tract cancers	Annals of Oncology. 2021 Jul;32(Suppl. 3):S146-S147.
2006-05	Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer	Journal of Gastroenterology and Hepatology. 2006 May;21(5):874-879.

顯示項目9026-9050 / 12927. (共518頁) << < 357 358 359 360 361 362 363 364 365 366 > >> 每頁顯示[10|25|50]項目